Minjuvi listed on Australia's PBS for lymphoma treatment
August 03, 2026 | 15:09
Specialised Therapeutics announced the listing of Minjuvi, in combination with rituximab and lenalidomide, on Australia's Pharmaceutical Benefits Scheme for the treatment of follicular lymphoma patients.
Mobile Version